Cookson 1986.
Methods | Allocation: randomised ‐ seperate sequences for males and females. Blindness: double. Duration: 1 year. Statistics: last observation carried forward. | |
Participants | History: 1 year of treatment with fluphenazine decanoate, overweight BMI 25+, physically fit, stable during prev yr. N= 19. Age: range HD 26‐57 yrs/ FD 35‐60 yrs. Sex: 9 M, 10 F. Setting: community (depot injection clinic). | |
Interventions | 1. Haloperidol decanoate: dose mean not specified, frequency same as previous depot. N=10. 2. Fluphenazine decanoate: dose mean not specified. N=9. Dose ratio: 4:1 (HD/FD). | |
Outcomes | Leaving the study early. Unable to use ‐ Mental state (CPRS, Kraweicka ‐Goldberg Scale ‐ no data). Side effects (Simpson & Angus Scale/ AIMS ‐ no data). Physiological measures (prolactin), weight measures ‐ non clinical outcomes, data not usuable). |
|
Notes | No usuable continuous data. Authors contacted ‐ no reply. | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Allocation concealment? | Unclear risk | B ‐ Unclear |